Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference

Rhea-AI Summary

Veracyte, Inc (Nasdaq: VCYT) announced that its CEO Bonnie Anderson will present at the 23rd Annual Needham Virtual Growth Conference on January 13, 2021, at 4:15 p.m. ET. A live audio webcast of the presentation will be accessible via the company’s website, with a replay available for 90 days thereafter. Veracyte is a global genomic diagnostics company focused on improving patient care through advanced genomic testing for diseases such as cancer.

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie Anderson, chairman and chief executive officer, will present at the 23rd Annual Needham Virtual Growth Conference on Wednesday, January 13, 2021, at 4:15 p.m. Eastern Time.

The link to the live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at https://investor.veracyte.com/events-presentations. A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005763/en/

FAQ

When is Veracyte's presentation at the Needham Growth Conference?

Veracyte's presentation at the 23rd Annual Needham Virtual Growth Conference is on January 13, 2021, at 4:15 p.m. ET.

How can I access the webcast of Veracyte's conference presentation?

The webcast for Veracyte's conference presentation can be accessed via their website at https://investor.veracyte.com/events-presentations.

What is Veracyte's stock symbol?

Veracyte's stock symbol is VCYT.

What does Veracyte do?

Veracyte is a global genomic diagnostics company that provides tests to improve patient care and inform diagnosis and treatment decisions.

What types of cancers does Veracyte test for?

Veracyte provides genomic tests for thyroid cancer, lung cancer, breast cancer, and is developing tests for lymphoma.